sodium-oxybate and Burns

sodium-oxybate has been researched along with Burns* in 2 studies

Trials

1 trial(s) available for sodium-oxybate and Burns

ArticleYear
Clinical sedation and bispectral index in burn children receiving gamma-hydroxybutyrate.
    Paediatric anaesthesia, 2012, Volume: 22, Issue:8

    Gamma-hydroxybutyrate (GHB) may be an interesting hypnotic agent in burn patients because of its good respiratory or hemodynamic tolerance. However, its clinical and electroencephalographic (EEG) sedative effects are not yet described in children. The aim of this prospective and randomized study was to assess clinical and EEG effects of increasing intravenous (IV) doses of GHB in burn children requiring sedation for burn wound cares.. Thirty six children hospitalized in a burn care unit were included and randomly assigned into three groups (G) according to the single IV dose of GHB they received before burn wound care: 10 mg · kg(-1) in G10, 25 mg · kg(-1) in G25, or 50 mg · kg(-1) in G50. All patients received oral premedication (morphine and hydroxyzine) 30 min before GHB injection. Respiratory rate, heart rate, pulse oximetry, and bispectral index (BIS) were continuously monitored. Depth of sedation was clinically assessed using Observer's Assessment of Alertness and Sedation (OAAS) Score, every 2 min until recovery (i.e., OAAS = 4).. Median age was 17.5 [12-34] months. Whatever the dose, BIS decreased after IV GHB. Nadir value of BIS was significantly lower in G25 and G50 than in G10, as was for OAAS score. Nadir values were reached after same delays in G25 and G50. Duration of sedation was dose-dependent.. Bispectral index decreased after GHB injection and was correlated with OAAS score. Deep sedation can be safely achieved with IV doses of 25 or 50 mg · kg(-1), but the last dose was associated with prolonged duration of clinical sedation.

    Topics: Burns; Child; Child, Preschool; Conscious Sedation; Consciousness Monitors; Electroencephalography; Female; Heart Rate; Humans; Hypnotics and Sedatives; Infant; Injections, Intravenous; Male; Oxygen; Pain Management; Propofol; Prospective Studies; Respiratory Rate; Sodium Oxybate

2012

Other Studies

1 other study(ies) available for sodium-oxybate and Burns

ArticleYear
The effects of gammahydroxybutyrate on hypermetabolism and wound healing in a rat model of large thermal injury.
    The Journal of trauma, 2007, Volume: 63, Issue:5

    Growth hormone (GH) improves wound healing and ameliorates pediatric postburn tissue catabolism associated with deficient endogenous GH/IGF-1 levels. Expense, parenteral administration, and compliance have limited widespread usage. Gammahydroxybutyrate (GHB), an upstream neuromodulatory gamma-amino butyric acid (GABA) derivative, is known to increase slow wave sleep and stimulate endogenous GH secretion. In this study, improvement in GH levels in turn has been shown to accelerate wound healing.. Body composition in male Sprague-Dawley rats with > or =40% total body surface area scald burn, receiving incremental GHB doses orally, was assessed by Dual Energy X-Ray Absorptiometry. Serum GH and IGF-1 levels were measured. Wound cross sections were scored semiquantitatively for wound healing variables.. Incremental elevation in GH and IGF-1 were associated with significantly improved wound edge epithelialization and cell-layer thickness at high doses (p < 0.005). However, body composition was similar to that of burned controls.. GHB sufficiently elevated serum GH and IGF-1 levels to significantly improve epithelialization rates and layer thickness at high doses. Substantially greater elevations of serum GH and IGF-1 levels are required in the rat burn model than for humans. GHB may improve postburn hypermetabolism in humans by elevating endogenous GH levels, though only improved epithelialization was demonstrated in this study.

    Topics: Anesthetics, Intravenous; Animals; Body Composition; Bone Density; Burns; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Growth Hormone; Insulin-Like Growth Factor I; Male; Metabolic Diseases; Prospective Studies; Random Allocation; Rats; Rats, Sprague-Dawley; Sleep; Sodium Oxybate; Treatment Outcome; Wound Healing

2007